Medication safety review for people with IDD
Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy, Mental health clinical trials.
This study checks how your genes affect your response to medications, aiming to improve medication safety for people with intellectual or developmental disabilities (IDD) who live in CP Unlimited facilities in New York. If you join, you'll provide a cheek swab to learn if your current or future medicines might be safer or work better for you based on your DNA.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have an intellectual or developmental disability (IDD).
- You must live in a CP Unlimited facility in New York state.
- You must be at least 21 years old.
- You cannot be pregnant.
- You must be able to have a cheek swab (a quick, painless cheek brush) collected.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using genetic information in the emergency department can help choose safer medications for patients 40 and older. It focuses on people who frequently visit the ER and are starting a new long-term medication.
This study collects blood, urine, and cheek swabs, along with health information, to see how your genes affect your response to medications. You may be eligible if you take many medications or are on blood pressure or depression medication.
This trial tests whether a pharmacist review of your medications, plus information from a pharmacogenomic (PGx) test (which looks at how your genes affect your response to drugs), can help improve your medication plan. If you qualify, you'll get a free PGx test and a personalized medication review.
This trial checks if genetic testing can help doctors pick safer drugs for you when you are in the hospital or visiting a clinic. If you qualify, you will give a cheek swab and be followed for about 12 weeks.
This study looks at whether a person’s genetic makeup can help choose safer medicines or improve how well treatment works. You may be asked for testing if you’ve had a bad reaction or treatment failure, or if you’re starting a new medicine that is known to be affected by genetics.
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
Hear when a new Developmental Disability trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.